State Street Corp Veracyte, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Veracyte, Inc. stock. As of the latest transaction made, State Street Corp holds 4,327,027 shares of VCYT stock, worth $92.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,327,027
Previous 3,108,639
39.19%
Holding current value
$92.9 Million
Previous $85.5 Million
12.12%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VCYT
# of Institutions
257Shares Held
81.7MCall Options Held
43KPut Options Held
82K-
Vanguard Group Inc Valley Forge, PA7.38MShares$159 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.37MShares$158 Million0.03% of portfolio
-
Black Rock Inc. New York, NY7.21MShares$155 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.04MShares$151 Million1.11% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.47MShares$74.4 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.54B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...